
Envista (NYSE:NVST) reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
On the company’s first-quarter earnings call, President and CEO Paul Keel said Envista posted 9.5% core growth in the quarter, marking the fourth consecutive quarter in which all of its major businesses grew. Orthodontics, consumables and diagnostics each grew double digits, while implants grew mid-single digits excluding China.